Baldessarini RJDrugs and treatment of psychiatric disorders . In: Gilman AG, Goodwin LS, Gilman, eds. Goodman and Gilman's Pharmacological Basis of Therapeutics. New York, NY: Macmillan Publishing Co; 1980:420.
2.
Baca L., Martiinelli L.Neuroleptic malignant syndrome: a unique association with a tricyclic antidepressant . Neurology. 1990;40:1797-1798.
3.
Schibuk M., Schachter D.A role for catecholamines in the pathogenesis of neuroleptic malignant syndrome . Can J Psychiatry. 1986;31:66-69.
4.
Mogilnicka E. , Klimek V., Nowak G., Czyrak A.Adaptive and differential changes on beta and alpha-2 adrenoreceptor-mediated hyperthermia after chronic treatment with antidepressant drugs in the rat kept at high ambient temperature . J Neural Transm1985;63:237-246.
5.
Pawowski L., Kwiatek H.The effect of highly selective inhibitors of the uptake of noradrenaline or 5-hydroxytyramine on TRH-induced hyperthermia in mice. Psychopharmacology . 1983;81:48-53.
6.
Petersdorf RGAlterations in body temperature. In: Isselbacher KJ, ed. Harrison's Principles of Internal Medicine. New York, NYMcGraw Hill; 1980.
